NCT06695845 · Interventional trial
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
Overall registry status Recruiting
Phase 2
Conditions Breast Cancer, Colorectal Cancer, Endometrial Cancer, Esophageal Cancer, Gastric Cancer, Gastroesophageal Cancer, HER-2 Protein Overexpression, Non-small Cell Lung Cancer, Ovarian Cancer, Pancreatic Cancer, Salivary Gland Cancer, Urothelial Carcinoma
Delaware Valley sites
- Alliance Cancer Specialists · Horsham, PA · Montgomery County · Withdrawn
First posted
Registry updated
Added to the directory